Direktorat Registrasi ObatValid

XARELTO

BPOM Number: DKI1251602517B1
Approved: 21 November 2024
Expiry: 11 January 2027
Form: TABLET SALUT SELAPUT; 15 MG

About This Registration

XARELTO is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1251602517B1. Its current registration status is Valid, with the licence valid until 11 January 2027. The product is registered to BAYER INDONESIA and manufactured by BAYER INDONESIA - INDONESIA. BPOM first approved this registration in January 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 2 BLISTER @ 14 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

BAYER INDONESIA
Kota Jakarta Pusat, DKI Jakarta, Indonesia
NPWP: 010000768092000
owner
View profile →

Manufacturing Sites

BAYER INDONESIA - INDONESIA
KOTA DEPOK
primary
View profile →

Ingredients (1)

RIVAROXABAN

Market Intelligence

Owner Portfolio: BAYER INDONESIA holds 95 BPOM registrations
Manufacturer Scale: BAYER INDONESIA - INDONESIA produces 81 registered products
Registration Age: Registered for 4 years, 6 months
Expiry Status: Expires in 5 months